FDA Adverse Event Malfunction Summary report: N

COAGUCHEK® XS SYSTEM

MDR report key: 1792121 · Received August 10, 2010

Report

Report Number
1823260-2010-04733
Event Type
Malfunction
Date Received
August 10, 2010
Date of Event
August 5, 2010
Report Date
October 5, 2010
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
PMA / PMN Number
K062925
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA.

Description of Event or Problem · 1

A TECHNICIAN REPORTS THAT DURING REFRACTIVE SURGERY, THE PT WAS NOT ABLE TO SEE THE FIXATION LIGHT. THE PROCEDURE ON BOTH EYES WAS COMPLETED THAT DAY. AT ONE DAY POST-OP, UCVA ON BOTH RIGHT AND LEFT EYE OF THIS PT WAS 20/20. THE SURGEON HAS NO CONCERNS FOR THIS PT'S OUTCOME.

Description of Event or Problem · 1

CALLER STATES THAT SHE TESTED 3.2 INR ON THE COAGUCHEK XS SYSTEM AND 2.4 INR ON A COMPARISON LAB. NO ACTIONS WERE REPORTED TAKEN OR TREATMENT RECEIVED. NO ADVERSE EVENT REPORTED. A REQUEST WAS MADE FOR THE RETURN OF THE AFFECTED PRODUCT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COAGUCHEK® XS SYSTEM PROTHROMBIN TIME TEST STRIPS GJS ROCHE DIAGNOSTICS NA 20180123

Patients

Seq Age Sex Outcome Treatment
1 051 YR MULTIVITAMIN| LEVOXYL| "SYROID EXTRNET"| TESTOSTERONE| SIMVASTATIN| NEXIUM| METOPROLOL| COUMADIN (DAILY)